Novel strategy targeting breast cancer stem cells CD44+/CD24-low responsible for breast cancer progression

被引：1
|
作者：
Abouelnazar, Fatma A. [1 ,2 ]
Sultan, Ahmed S. [1 ]
机构：
[1] Alexandria Univ, Fac Sci, Alexandria, Egypt
[2] Pharos Univ, Fac Allied Med Sci, Alexandria, Egypt
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
160
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Expression of CD44+/CD24- Cells in Breast Cancer
    Lu, X. Q.
    Suo, Z. H.
    Ma, C. L.
    Xu, K. J.
    Liu, Y. S.
    Li, H. X.
    LABORATORY INVESTIGATION, 2009, 89 : 55A - 55A
  • [2] Expression of CD44+/CD24- Cells in Breast Cancer
    Lu, X. Q.
    Suo, Z. H.
    Ma, C. L.
    Xu, K. J.
    Liu, Y. S.
    Li, H. X.
    MODERN PATHOLOGY, 2009, 22 : 55A - 55A
  • [3] The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation
    Phillips, Tiffany M.
    McBride, William H.
    Pajonk, Frank
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (24): : 1777 - 1785
  • [4] The distribution of CD44+/CD24-cancer stem cells in breast cancer and its relationship with prognostic factors
    Cabuk, Devrim
    Yetimoglu, Eylem
    Simsek, Turgay
    Gacar, Gulcin
    Subasi, Cansu
    Canturk, Zafer
    Ercin, Cengiz
    Karaoz, Erdal
    Uygun, Kazim
    JOURNAL OF BUON, 2016, 21 (05): : 1121 - 1128
  • [5] Runx2 is required for activity of CD44+/CD24-/low breast cancer stem cell in breast cancer development
    Zhang, Ping
    Liu, Lei
    Zhang, Lu
    He, Xiaogan
    Xu, Xiaojun
    Lu, Yaojuan
    Li, Feifei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (05): : 2305 - 2318
  • [6] CD44+/CD24- cancer stem cell in breast tissue distribution and prevalence
    Swiatek, J.
    Kaerner, A.
    Heil, J.
    Aulmann, S.
    Sinn, H.
    Sohn, C.
    Gebauer, G.
    ONKOLOGIE, 2008, 31 : 51 - 52
  • [7] STAT1 promotes radioresistance of CD44+/CD24-/low cells in breast cancer
    Zhan, Jun-fang
    Chen, Long-hua
    Yuan, Ya-wei
    Xie, Guo-zhu
    Sun, Ai-min
    Liu, Ying
    Chen, Zhi-xian
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 236 (04) : 418 - 422
  • [8] Reduction of CD44+/CD24- breast cancer cells by conventional cytotoxic chemotherapy
    Aulmann, Sebastian
    Waldburger, Nina
    Penzel, Roland
    Andrulis, Mindaugas
    Schirmacher, Peter
    Sinn, Hans Peter
    HUMAN PATHOLOGY, 2010, 41 (04) : 574 - 581
  • [9] Ribosome biogenesis mediates antitumor activity of flavopiridol in CD44+/CD24- breast cancer stem cells
    Erol, Ayse
    Acikgoz, Eda
    Guven, Ummu
    Duzagac, Fahriye
    Turkkani, Ayten
    Colcimen, Nese
    Oktem, Gulperi
    ONCOLOGY LETTERS, 2017, 14 (06) : 6441 - 6448
  • [10] CD44+ enriches for cancer initiating cells while CD44+CD24+ and CD44+CD24- cells are equally tumorigenic in basal-like breast cancer
    Vonderhaar, B.
    Meyer, M.
    Fleming, J.
    Ginsburg, E.
    Bush, A.
    Ali, M.
    Lieber, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 19 - 19
12345